Nobody has filed for crossing 5%. That is a fact, not missing data.
MNRO planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
MNRO mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Gabelli Global Mini Mites Fund
$479.1K position · as of 2026-06-30
1.8%
State Street(R) SPDR(R) S&P(R) Retail ETF
$4.9M position · as of 2026-06-30
1.3%
CRAWFORD SMALL CAP DIVIDEND FUND
$4.1M position · as of 2026-06-30
1.1%
FULLERTHALER BEHAVIORAL MICRO-CAP EQUITY FUND
$284.0K position · as of 2026-06-30
0.9%
Small Cap Portfolio
$3.4M position · as of 2026-06-30
0.9%
BNY Mellon Small Cap Value Fund
$2.7M position · as of 2026-06-30
0.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · M. Broderick
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$6.5M
$5.4M
$1.1M
-72%
+37%
2024
$2.7M
$753.9K
$986.0K
-54%
+151%
2023
$1.7M
$619.4K
$1.0M
-14%
+158%
2022
$1.6M
$1.5M
$935.2K
+30%
+88%
2021
$4.6M
$3.1M
$1.2M
+14%
+94%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 93 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.2B
four quarters, 2025-03-30 to 2026-03-28
Revenue, TTM MNRO
FY Mar 2026
$1.2B
FY Mar 2025
$1.2B
FY Mar 2024
$1.3B
FY Mar 2023
$1.3B
FY Mar 2022
$1.4B
Mar 2026
$273.8M
Dec 2025
$293.4M
Sep 2025
$288.9M
Jun 2025
$301.0M
Mar 2025
$295.0M
Dec 2024
$305.8M
Sep 2024
$301.4M
Jun 2024
$293.2M
At each fiscal year end
Single quarter
Net margin, TTM
+0.2%
net income over revenue, 2025-03-30 to 2026-03-28
Net margin, TTM MNRO
FY Mar 2026
+0.2%
FY Mar 2025
-0.4%
FY Mar 2024
+2.9%
FY Mar 2023
+2.9%
FY Mar 2022
+4.5%
Mar 2026
-2.4%
Dec 2025
+3.8%
Sep 2025
+2.0%
Jun 2025
-2.7%
Mar 2025
-7.2%
Dec 2024
+1.5%
Sep 2024
+1.9%
Jun 2024
+2.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$38.8M
operating cash flow minus capex, 2025-03-30 to 2026-03-28
Free cash flow, TTM MNRO
FY Mar 2026
$38.8M
FY Mar 2025
$105.5M
FY Mar 2024
$99.7M
FY Mar 2023
$176.0M
FY Mar 2022
$145.9M
Mar 2026
$12.4M
Dec 2025
$9.1M
Sep 2025
$26.6M
Jun 2025
-$9.3M
Mar 2025
$23.2M
Dec 2024
$7.9M
Sep 2024
$57.6M
Jun 2024
$16.8M
At each fiscal year end
Single quarter
Debt to equity
0.10x
long-term 2026-03-28 plus current 2019-03-30 (85 months older than the period end); equity 2026-03-28
Debt to equity MNRO
FY Mar 2026
0.10x
FY Mar 2025
0.10x
FY Mar 2024
0.16x
FY Mar 2023
0.15x
FY Mar 2022
0.23x
Mar 2026
0.10x
Dec 2025
0.07x
Sep 2025
0.10x
Jun 2025
0.12x
Mar 2025
0.10x
Dec 2024
0.09x
Sep 2024
0.10x
Jun 2024
0.17x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.17x
TTM operating cash flow over long-term 2026-03-28 plus current 2019-03-30 (85 months older than the period end)
Cash flow to debt MNRO
FY Mar 2026
1.17x
FY Mar 2025
2.15x
FY Mar 2024
1.23x
FY Mar 2023
2.05x
FY Mar 2022
0.98x
Mar 2026
1.17x
Dec 2025
1.71x
Sep 2025
1.23x
Jun 2025
1.46x
Mar 2025
2.15x
Dec 2024
1.65x
Sep 2024
1.86x
Jun 2024
0.71x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+0.4%
TTM net income over average of 2025-03-29 and 2026-03-28
Return on equity MNRO
FY Mar 2026
+0.4%
FY Mar 2025
-0.8%
FY Mar 2024
+5.6%
FY Mar 2023
+5.3%
FY Mar 2022
+8.0%
Mar 2026
+0.4%
Dec 2025
-2.0%
Sep 2025
-3.0%
Jun 2025
-3.0%
Mar 2025
-0.8%
Dec 2024
+3.0%
Sep 2024
+4.1%
Jun 2024
+5.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.1%
TTM net income over average of 2025-03-29 and 2026-03-28
Return on assets MNRO
FY Mar 2026
+0.1%
FY Mar 2025
-0.3%
FY Mar 2024
+2.2%
FY Mar 2023
+2.1%
FY Mar 2022
+3.3%
Mar 2026
+0.1%
Dec 2025
-0.8%
Sep 2025
-1.2%
Jun 2025
-1.2%
Mar 2025
-0.3%
Dec 2024
+1.2%
Sep 2024
+1.6%
Jun 2024
+2.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+2.2%
operating income after a 29.9% effective tax rate, over long-term 2026-03-28 plus current 2019-03-30 (85 months older than the period end) plus average of 2025-03-29 and 2026-03-28 minus cash
Return on invested capital MNRO
FY Mar 2026
+2.2%
FY Mar 2025
n/a
FY Mar 2024
+6.7%
FY Mar 2023
+6.5%
FY Mar 2022
+8.7%
Mar 2026
+2.2%
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+4.8%
Sep 2024
+5.7%
Jun 2024
+6.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+1.8%
operating income (EBIT proxy) over average of 2025-03-29 and 2026-03-28 minus current liabilities
Return on capital employed MNRO
FY Mar 2026
+1.8%
FY Mar 2025
+1.1%
FY Mar 2024
+5.6%
FY Mar 2023
+5.5%
FY Mar 2022
+6.6%
Mar 2026
+1.8%
Dec 2025
+0.1%
Sep 2025
-0.6%
Jun 2025
-0.6%
Mar 2025
+1.1%
Dec 2024
+3.9%
Sep 2024
+4.8%
Jun 2024
+5.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
661.50x
close 2026-10-23 over four quarters of diluted EPS, 2025-03-30 to 2026-03-28
P/E, trailing MNRO
FY Mar 2026
773.50x
FY Mar 2025
n/a
FY Mar 2024
26.50x
FY Mar 2023
40.44x
FY Mar 2022
24.38x
Mar 2026
773.50x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
38.09x
Sep 2024
32.77x
Jun 2024
21.69x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$442.6M
market value at close 2026-10-23 on 2026-05-15 shares, plus long-term 2026-03-28 plus current 2019-03-30 (85 months older than the period end), minus cash 2026-03-28
Enterprise value MNRO
FY Mar 2026
$509.8M
FY Mar 2025
$517.3M
FY Mar 2024
$1.0B
FY Mar 2023
$1.6B
FY Mar 2022
$1.6B
Mar 2026
$509.8M
Dec 2025
$664.5M
Sep 2025
$609.6M
Jun 2025
$503.4M
Mar 2025
$517.3M
Dec 2024
$790.7M
Sep 2024
$904.1M
Jun 2024
$807.2M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.8%
TTM free cash flow over market value at close 2026-10-23
FCF yield MNRO
FY Mar 2026
+8.4%
FY Mar 2025
+22.1%
FY Mar 2024
+10.6%
FY Mar 2023
+11.5%
FY Mar 2022
+9.9%
Mar 2026
+8.4%
Dec 2025
+7.9%
Sep 2025
+8.6%
Jun 2025
+18.1%
Mar 2025
+22.1%
Dec 2024
+9.5%
Sep 2024
+10.6%
Jun 2024
+7.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing MNRO
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
0.31x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MNRO ranks highest on financial health (77th percentile) and institutional and government (50th), and lowest on growth (27th), among Services peers.
Profitability
33
Inputs
Return on equity+0.4% · 38 pct, sector of 207
Return on assets+0.1% · 47 pct, sector of 269
Return on invested capital+2.2% · 5 pct, sector of 81
Return on capital employed+1.8% · 44 pct, sector of 203
Financial health
77
Inputs
Debt to equity0.10x · 70 pct, sector of 228
Cash flow to debt1.17x · 84 pct, sector of 199
Growth
27
Inputs
Revenue growth, YoY-3.2% · 27 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
50
Inputs
Funds adding, latest quarter93 · 50 pct, sector of 243
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
33
Inputs
Short interest, % of float+25.7% · 2 pct, sector of 383
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+8.6% · 64 pct, sector of 227
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.